Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

Clinical trial NCT02898454 · COMPLETED

Trial details

NCT number: NCT02898454
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)

Start date: 2016-11-28
Primary completion: 2018-08-27
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.